Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Byerly

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Schizophrenia Research|November 22, 2005
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorderMatthew J Byerly, Paul A Nakonezny, Robert Fisher, et al.
Psychiatric Services (Washington, D.C.)|April 30, 2003
Cost evaluation of risperidone compared with olanzapineMatthew J Byerly, Mary Weber, Deean Brooks, et al.
Psychiatric Services (Washington, D.C.)|May 31, 2007
Validity of electronically monitored medication adherence and conventional adherence measures in schizophreniaMatthew J Byerly, Ann Thompson, Thomas Carmody, et al.
Schizophrenia Research|May 30, 2006
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapineMatthew J Byerly, Paul A Nakonezny, Brianne Magouirk Bettcher, et al.
Schizophrenia Research|November 29, 2008
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label studyMatthew J Byerly, Ronald N Marcus, Quynh-Van Tran, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|June 5, 2019
Feasibility and Acceptability of the Youth Aware of Mental Health (YAM) Intervention in US AdolescentsJanet C Lindow, Jennifer L Hughes, Charles South, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 3, 2020
The Youth Aware of Mental Health Intervention: Impact on Help Seeking, Mental Health Knowledge, and Stigma in U.S. AdolescentsJanet C Lindow, Jennifer L Hughes, Charles South, et al.
Journal of Sex & Marital Therapy|January 28, 2005
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunctionMatthew J Byerly, Emmeline Lescouflair, Mary T Weber, et al.
Schizophrenia Research|April 10, 2020
A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophreniaPaul A Nakonezny, Janet C Lindow, T Scott Stroup, et al.
Journal of Medical Internet Research|November 19, 2019
Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled TrialMark B Schure, Janet C Lindow, John H Greist, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Schizophrenia Research|November 22, 2005
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorderMatthew J Byerly, Paul A Nakonezny, Robert Fisher, et al.
Psychiatric Services (Washington, D.C.)|April 30, 2003
Cost evaluation of risperidone compared with olanzapineMatthew J Byerly, Mary Weber, Deean Brooks, et al.
Psychiatric Services (Washington, D.C.)|May 31, 2007
Validity of electronically monitored medication adherence and conventional adherence measures in schizophreniaMatthew J Byerly, Ann Thompson, Thomas Carmody, et al.
Schizophrenia Research|May 30, 2006
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapineMatthew J Byerly, Paul A Nakonezny, Brianne Magouirk Bettcher, et al.
Schizophrenia Research|November 29, 2008
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label studyMatthew J Byerly, Ronald N Marcus, Quynh-Van Tran, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|June 5, 2019
Feasibility and Acceptability of the Youth Aware of Mental Health (YAM) Intervention in US AdolescentsJanet C Lindow, Jennifer L Hughes, Charles South, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|March 3, 2020
The Youth Aware of Mental Health Intervention: Impact on Help Seeking, Mental Health Knowledge, and Stigma in U.S. AdolescentsJanet C Lindow, Jennifer L Hughes, Charles South, et al.
Journal of Sex & Marital Therapy|January 28, 2005
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunctionMatthew J Byerly, Emmeline Lescouflair, Mary T Weber, et al.
Schizophrenia Research|April 10, 2020
A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophreniaPaul A Nakonezny, Janet C Lindow, T Scott Stroup, et al.
Journal of Medical Internet Research|November 19, 2019
Use of a Fully Automated Internet-Based Cognitive Behavior Therapy Intervention in a Community Population of Adults With Depression Symptoms: Randomized Controlled TrialMark B Schure, Janet C Lindow, John H Greist, et al.
Pageof 3